Last reviewed · How we verify
NCT05772949
Effectiveness of a Smart Hearing Aid on Improving Psychosocial Well-being in Elderly
NA trial testing Experimental group intervention in Technology in 33 participants. Completed in 12 September 2023.
12 September 2023
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 33 |
| Start date | 7 March 2023 |
| Primary completion | 12 September 2023 |
| Estimated completion | 12 September 2023 |
| Sites | 3 locations across Hong Kong |
Drugs / interventions tested
- Experimental group intervention
- Wait-list control group intervention
Conditions studied
- Technology — all drugs for Technology →
Sponsor
The University of Hong Kong
Who can join
Eligibility, any sex, with Technology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study has 2 primary research questions, 4 secondary research questions, and 2 auxiliary research questions targeting elderly with hearing impairment. The research questions are: Primary study questions: 1. Can the use of the smart hearing aids reduce loneliness at the end of intervention? 2. Can the use of the smart hearing aids improve quality of life at the end of intervention? Secondary study questions: 3. Can the use of the smart hearing aids improve the communication quality between caregivers and participants at the end of intervention? 4. How is the satisfaction of the participants with the smart hearing aids? 5. What are the factors leading to the use and non-use of the smart hearing aids? 6. What is the usage time of the smart hearing aids? Auxiliary study questions: 7. How is the caregiver burden when facilitating the participants to use the smart hearing aids? 8. What are the perceived benefits and acceptability of the smart hearing aids?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05772949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental group intervention
Trials testing the same drug.
- NCT05404802 — Therapeutic Effectiveness of PARO Companion Robot for Elderly With Mild Cognitive Impairment/Dementia in Elderly Residen · NA · completed
Other recruiting trials for Technology
Currently open trials in the same condition.
- NCT06485856 — ASSESSMENT OF PAIN USING A PAIN DIAGNOSTIC SYSTEM THAT MEASURS FACIAL MOVEMENT USING · NA · recruiting
- NCT05086757 — Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors · NA · recruiting
- NCT05293756 — OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) · NA · recruiting
- NCT05615259 — Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05772949 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing